AI assistant
Q32 Bio Inc. — Director's Dealing 2024
Mar 27, 2024
34891_dirs_2024-03-27_11cc6e39-cc68-4a07-86cb-328a0f56200c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Q32 Bio Inc. (QTTB)
CIK: 0001661998
Period of Report: 2024-03-25
Reporting Person: Lundberg Sven Ante (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1200 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $3.13 | 2028-12-06 | Common Stock (2013) | Direct | |
| Stock Option (Right to Buy) | $3.13 | 2028-12-06 | Common Stock (6238) | Direct | |
| Stock Option (Right to Buy) | $7.29 | 2031-01-21 | Common Stock (2880) | Direct |
Footnotes
F1: 25% of the shares underlying this option vested and became exercisable on July 26, 2019, with the remainder vesting in twelve (12) equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
F2: 25% of the shares underlying this option vested and became exercisable on September 17, 2020, with the remainder vesting in twelve (12) equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
F3: The shares underlying this option vest in sixteen (16) equal quarterly installments following December 2, 2020, subject to the Reporting Person's continued service on each such vesting date.